Publications
- Targeting of the Mitochondrial TET1 Protein by Pyrrolo[3,2-b]pyrrole Chelators2022 | First Faculty of Medicine
- Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells2022 | First Faculty of Medicine
- Benzoisothiazole-1,1-dioxide-based synthetic receptor for zinc ion recognition in aqueous medium and its interaction with nucleic acids2019 | First Faculty of Medicine
- Hydrazones as novel epigenetic modulators: Correlation between TET 1 protein inhibition activity and their iron(II) binding ability2019 | First Faculty of Medicine
- Azulene hydrazido-hydrazones and their use for the treatment of oncological diseasesPublication without faculty affiliation
- Engine shutdown: Migrastatic strategies and prevention of metastases2023 | First Faculty of Medicine, Faculty of Science
- Preparation of Tryptanthrin Derivates Bearing a Thiosemicarbazone Moiety to Inhibit SARS-CoV-2 Replication2023 | First Faculty of Medicine
- Therapeutic potential and limitations of curcumin as antimetastatic agent2023 | First Faculty of Medicine
- TET protein inhibitors: Potential and limitations2023 | First Faculty of Medicine
- Combination of quinoxaline with pentamethinium system: Mitochondrial staining and targeting2023 | First Faculty of Medicine
Loading network view...